Understanding the Requirements of Direct to Patient Trials (WS7)

24 April 2018
Available Seats:

Ensuring safety and quality are maintained when direct to patient clinical supplies distribution occurs remains a major Supply Chain concern.  Dynamic enrollment, aggressive recruitment, confidentiality and drug supply/ cost are driving the industry to find alternative ways to supply IMP closer to the patient.  This workshop will provide a forum for discussing ideas and solutions to the overcome/ prevent issues with direct shipments to patients.

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.